Biotech stocks

Companies

146

Combined market cap

$708.8B

Median PE

25.8×

Median revenue growth

+10.1%

Median net margin

15.0%

Company	Market cap	PE	P/S	Revenue growth	Net margin	Dividend yield
VRTXVertex Pharmaceuticals	$132.8B	30.5×	10.6×	+10%	35.0%	n/m
REGNRegeneron Pharmaceuticals	$82.9B	19.9×	5.3×	+9%	27.9%	0.46%
MRNAModerna	$79.9B	n/m	35.9×	−28%	n/m	n/m
ONCBeOne Medicines	$42.9B	67.6×	7.0×	+34%	10.7%	n/m
RVMDRevolution Medicines	$40.1B	n/m	n/m	n/m	n/m	n/m
ALNYAlnylam Pharmaceuticals	$30B	37.8×	6.2×	+95%	16.8%	n/m
ROIVRoivant Sciences	$26.4B	n/m	n/m	−68%	n/m	n/m
UTHRUnited Therapeutics	$25.2B	21.0×	8.0×	+2%	41.6%	n/m
INCYIncyte	$23.5B	14.7×	4.0×	+27%	27.7%	n/m
INSMInsmed	$20.4B	n/m	17.9×	+186%	−76.9%	n/m
EXELExelixis	$16B	20.3×	6.6×	+9%	35.3%	n/m
NBIXNeurocrine Biosciences	$14.5B	20.9×	4.3×	+34%	20.9%	n/m
HALOHalozyme Therapeutics	$14.3B	37.5×	8.6×	+41%	24.9%	n/m
TECHBIO-TECHNE	$11.4B	63.1×	9.4×	−0%	15.0%	n/m
RGENRepligen	$10B	242×	12.7×	+16%	5.3%	n/m
KRYSKrystal Biotech	$9.2B	39.0×	20.9×	+23%	54.8%	n/m
KYMRKymera Therapeutics	$9.2B	n/m	87.7×	+135%	n/m	n/m
PCVXVaxcyte	$9B	n/m	n/m	n/m	n/m	n/m
TWSTTwist Bioscience	$8.8B	n/m	20.3×	+19%	−31.7%	n/m
IBRXImmunityBio	$8.7B	n/m	52.5×	+193%	n/m	n/m
IOVAIovance Biotherapeuticscaveat	$6.4B	n/m	19.6×	+35%	−89.1%	n/m
IMVTImmunovantcaveat	$5.9B	n/m	n/m	n/m	n/m	n/m
KODKodiak Sciences	$5.5B	n/m	n/m	n/m	n/m	n/m
CGONCG Oncology	$5.5B	n/m	n/m	n/m	n/m	n/m
SRRKScholar Rock	$5.1B	n/m	n/m	n/m	n/m	n/m
CRSPCRISPR Therapeutics	$4.8B	n/m	n/m	−65%	n/m	n/m
ADPTAdaptive Biotechnologies	$4.1B	n/m	13.2×	+50%	−20.7%	n/m
RLAYRelay Therapeuticscaveat	$4B	n/m	n/m	+24%	n/m	n/m
TARSTarsus Pharmaceuticals	$3B	n/m	4.9×	+105%	−7.7%	n/m
DNLIDenali Therapeuticscaveat	$2.9B	n/m	n/m	n/m	n/m	n/m
BEAMBeam Therapeutics	$2.5B	n/m	15.9×	+159%	−54.7%	n/m
ADMAAdma Biologics	$2.4B	15.3×	4.7×	+8%	33.0%	n/m
VCELVericel	$2.2B	92.5×	7.1×	+23%	7.9%	n/m
RXRXRecursion Pharmaceuticals	$2B	n/m	36.1×	−15%	n/m	n/m
BCRXBiocryst Pharmaceuticals	$2B	n/m	2.1×	+69%	−40.9%	n/m
VIRVir Biotechnology	$1.8B	n/m	5.9×	n/m	−83.0%	n/m
MAZEMaze Therapeuticscaveat	$1.7B	n/m	n/m	n/m	n/m	n/m
COAGHemab Therapeuticscaveat	$1.6B	n/m	n/m	n/m	n/m	n/m
NVAXNovavax	$1.6B	n/m	3.9×	−62%	−59.9%	n/m
IMCRImmunocore	$1.6B	n/m	3.7×	+21%	−4.2%	n/m
INBXInhibrx Biosciencescaveat	$1.4B	n/m	n/m	n/m	n/m	n/m
TSHATaysha Gene Therapies	$1.3B	n/m	n/m	−32%	n/m	n/m
VORVor Biopharma	$1.1B	n/m	n/m	n/m	n/m	n/m
REPLReplimune	$1.1B	n/m	n/m	n/m	n/m	n/m
ODTXOdyssey Therapeuticscaveat	$941.9M	n/m	n/m	n/m	n/m	n/m
GLUEMonte Rosa Therapeutics	$924.8M	n/m	32.2×	−84%	n/m	n/m
CGEMCullinan Therapeuticscaveat	$924.8M	n/m	n/m	n/m	n/m	n/m
MGTXMeiraGTx	$884.6M	13.0×	2.2×	n/m	19.9%	n/m
SCNIScinai Immunotherapeuticscaveat	$783.1M	n/m	n/m	n/m	n/m	n/m
SANASana Biotechnology	$697.5M	n/m	n/m	n/m	n/m	n/m
DNAGinkgo Bioworkscaveat	$672.7M	n/m	6.0×	−47%	n/m	n/m
PRMEPrime Medicine	$665.7M	n/m	163×	−18%	n/m	n/m
AURAAura Biosciences	$653.3M	n/m	n/m	n/m	n/m	n/m
SLDBSolid Biosciences	$634.8M	n/m	n/m	n/m	n/m	n/m
ATTOAttovia Therapeuticscaveat	$631.4M	n/m	n/m	n/m	n/m	n/m
CADLCandel Therapeutics	$614.4M	n/m	n/m	n/m	n/m	n/m
FDMT4D Molecular Therapeuticscaveat	$596.6M	n/m	6.5×	n/m	n/m	n/m
DBVTDBV Technologies	$577.3M	n/m	115×	+32%	n/m	n/m
ENTXEntera Bio	$505.6M	n/m	n/a	−100%	n/a	n/m
RGNXREGENXBIO	$441M	n/m	2.5×	+12%	n/m	n/m
ALLOAllogene Therapeuticscaveat	$431.9M	n/m	n/m	n/m	n/m	n/m
PROKProkidney	$426.3M	n/m	n/m	+55%	n/m	n/m
AUTLAutolus Therapeutics	$409.9M	n/m	3.5×	+292%	n/m	n/m
EIKNEikon Therapeuticscaveat	$393.2M	n/m	n/m	n/m	n/m	n/m
TECXTectonic Therapeutic	$392.4M	n/m	n/m	n/m	n/m	n/m
CCCCC4 Therapeutics	$376.5M	n/m	10.7×	+2%	n/m	n/m
EDITEditas Medicine	$368.6M	n/m	7.8×	+21%	n/m	n/m
FENCFennec Pharmaceuticals	$353.5M	n/m	6.0×	+78%	−5.5%	n/m
KYTXKyverna Therapeuticscaveat	$333.3M	n/m	n/m	n/m	n/m	n/m
ZURAZura Bio	$322M	n/m	n/m	n/m	n/m	n/m
XFORX4 Pharmaceuticalscaveat	$321.2M	n/m	20.3×	−52%	n/m	n/m
ARTVArtiva Biotherapeutics	$300.7M	n/m	n/m	n/m	n/m	n/m
SRZNSurrozen	$299.5M	n/m	26.0×	−9%	n/m	n/m
SCTXScribe Therapeuticscaveat	$291.6M	n/m	n/m	n/m	n/m	n/m
AGENAgenus	$285M	n/m	2.1×	+30%	69.3%	n/m
IPSCCentury Therapeuticscaveat	$264.4M	n/m	n/m	n/m	n/m	n/m
SABSSAB Biotherapeuticscaveat	$258.4M	n/m	n/m	n/m	n/m	n/m
LCTXLineage Cell Therapeutics	$252.9M	n/m	19.3×	+20%	n/m	n/m
FATEFate Therapeutics	$252.8M	n/m	38.9×	−23%	n/m	n/m
OCGNOcugencaveat	$250.8M	n/m	n/m	n/m	n/m	n/m
CABACabaletta Biocaveat	$249.2M	n/m	n/m	n/m	n/m	n/m
PALIPalisade Biocaveat	$231.8M	n/m	n/m	n/m	n/m	n/m
LXEOLexeo Therapeutics	$229.7M	n/m	n/m	n/m	n/m	n/m
IKTInhibikase Therapeutics	$221.9M	n/m	n/m	n/m	n/m	n/m
PLXProtalix BioTherapeutics	$205.5M	11.1×	2.5×	+30%	23.5%	n/m
ALECAlector	$204.3M	n/m	14.7×	−83%	n/m	n/m
DTILPrecision Biosciences	$183.3M	n/m	4.1×	n/m	n/m	n/m
ACOGAlpha Cognition	$181.6M	n/m	11.9×	n/m	n/m	n/m
IVVDInvivyd	$180.8M	n/m	3.1×	+26%	n/m	n/m
CHRSCoherus Oncologycaveat	$156M	n/m	3.1×	+61%	n/m	n/m
STROSutro Biopharma	$154.7M	n/m	3.4×	−56%	n/m	n/m
ABOSAcumen Pharmaceuticals	$143.2M	n/m	n/m	n/m	n/m	n/m
TARAProtara Therapeuticscaveat	$137.7M	n/m	n/m	n/m	n/m	n/m
CMPXCompass Therapeuticscaveat	$137M	n/m	n/m	n/m	n/m	n/m
ARMPArmata Pharmaceuticals	$135.3M	n/m	n/m	n/m	n/m	n/m
OTLKOutlook Therapeuticscaveat	$126.4M	n/m	n/m	n/m	n/m	n/m
AVXLAnavex Life Sciences	$123.3M	n/m	n/m	n/m	n/m	n/m
HUMAHumacyte	$121M	n/m	57.0×	+159%	n/m	n/m
BDTXBlack Diamond Therapeutics	$108M	n/m	n/a	−100%	n/a	n/m
VYGRVoyager Therapeutics	$107.2M	n/m	3.1×	−19%	n/m	n/m
ENGNenGene Therapeutics	$104.5M	n/m	n/m	n/m	n/m	n/m
LENZLENZ Therapeutics	$99.3M	n/m	4.6×	n/m	n/m	n/m
TNYATenaya Therapeuticscaveat	$87.2M	n/m	n/m	n/m	n/m	n/m
ATRAAtara Biotherapeuticscaveat	$86.2M	n/m	n/m	n/m	n/m	n/m
NMRANeumora Therapeutics	$71.3M	n/m	n/m	n/m	n/m	n/m
CRDFCardiff Oncologycaveat	$70.6M	n/m	139×	−7%	n/m	n/m
CGTXCognition Therapeuticscaveat	$68.4M	n/m	n/m	n/m	n/m	n/m
CSBRChampions Oncologycaveat	$65.7M	n/m	1.1×	+7%	−1.8%	n/m
PTHSPelthos Therapeuticscaveat	$65.1M	n/m	1.5×	n/m	n/m	n/m
CRBUCaribou Biosciences	$57.1M	n/m	5.7×	+10%	n/m	n/m
INKTMiNK Therapeutics	$54.7M	n/m	n/m	n/m	n/m	n/m
ELOXEloxx Pharmaceuticalscaveat	$51.7M	n/m	n/m	n/m	n/m	n/m
IMAImageneBiocaveat	$47.9M	n/m	n/m	n/m	n/m	n/m
LONALeonaBio	$45.6M	n/m	n/m	n/m	n/m	n/m
KLRSKalaris Therapeuticscaveat	$44.5M	n/m	n/m	n/m	n/m	n/m
ESLAEstrella Immunopharma	$42.8M	n/m	n/m	n/m	n/m	n/m
TVGNTevogen	$42.5M	n/m	n/m	n/m	n/m	n/m
INMBInmune Biocaveat	$40.5M	n/m	n/m	n/m	n/m	n/m
TILInstil Bio	$39.6M	n/m	n/m	n/m	n/m	n/m
EXOZExozymes	$37.1M	n/m	n/m	n/m	n/m	n/m
ELUTElutia	$37.1M	n/m	3.1×	−18%	n/m	n/m
MGXMetagenomi Therapeuticscaveat	$30.4M	n/m	n/m	n/m	n/m	n/m
CVMCEL SCI	$28.8M	n/m	n/m	n/m	n/m	n/m
BSEMBioStem Technologiescaveat	$28M	n/m	n/m	n/m	n/m	n/m
BKHABlack Hawk Acquisitioncaveat	$22.4M	n/m	n/m	n/m	n/m	n/m
SCLXScilexcaveat	$20M	n/m	0.6×	−29%	n/m	n/m
GRMLGreenland Minescaveat	$18.4M	n/m	n/m	n/m	n/m	n/m
JSPRJasper Therapeutics	$17M	n/m	n/m	n/m	n/m	n/m
ATYRaTYR PHARMA INCcaveat	$16.2M	n/m	n/m	n/m	n/m	n/m
DYAIDyadic International	$14.5M	n/m	3.8×	−8%	n/m	n/m
BCDABioCardiacaveat	$13.9M	n/m	n/m	n/m	n/m	n/m
TCRXTScan Therapeutics	$13.8M	n/m	1.9×	+2%	n/m	n/m
PLURPluri	$12.2M	n/m	12.0×	−24%	n/m	n/m
PASGPassage BIO	$10.8M	n/m	n/m	n/m	n/m	n/m
INTSIntensity Therapeutics	$10.6M	n/m	n/m	n/m	n/m	n/m
INABIN8BIO	$10.4M	n/m	n/m	n/m	n/m	n/m
SNTISenti Biosciencescaveat	$5.9M	n/m	n/m	n/m	n/m	n/m
CELZCreative Medical Technology	$4.9M	n/m	n/m	−50%	n/m	n/m
AIMAIM ImmunoTech	$4.8M	n/m	50.1×	−21%	n/m	n/m
LIMNLiminatus Pharmacaveat	$3.9M	n/m	n/m	n/m	n/m	n/m
PMCBPharmaCyte Biotech	$3.8M	n/m	n/a	n/m	n/a	n/m
VIVSVivoSim Labs, INC.	$2.2M	n/m	19.7×	−21%	n/m	n/m
CLDICalidi Biotherapeutics	$1.6M	n/m	n/m	n/m	n/m	n/m
SLXNSilexion Therapeuticscaveat	$1M	n/m	n/m	n/m	n/m	n/m
CRISCuris	$807.4K	n/m	0.2×	−62%	n/m	n/m
ALGSAligos Therapeutics	n/a	n/m	n/m	+19%	n/m	n/m

Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.